{
  "id": "everyday#risk_safety_69c89b5a",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "thoughts. » Review management plan and monitor adherence to Go back to Assessment Step 4 for worsening mood. Go to » SUI psychosocial interventions. for suicidal thoughts. » If on medication, review adherence, side-effects, and dosing. » Explore and address psychosocial stressors in the home, school or work environment, including exposure to violence or other forms of maltreatment. CHILD & ADOLESCENT MENTAL & BEHAVIOURAL DISORDERS 91 92 CMH 3 CHILD & ADOLESCENT MENTAL & BEHAVIOURAL DISORDERS Follow-up 3 MONITOR PHARMACOLOGICAL TREATMENT AS APPLICABLE Additional monitoring if the adolescent Additional monitoring if the child has has been prescribed fluoxetine been prescribed methylphenidate Record prescription and administration details. Record prescription and administration details. Weekly for the first month, then every month: Monitor potential for misuse and diversion. monitor for reported side-effects and changes in mood and Every three months: monitor/record height, weight, blood other symptoms. pressure, reported side-effects, and changes in behaviour. Consult specialist if you identify severe medication side- Consult specialist if you observe medication side-effects effects or adverse events (e.g. new or worsening suicidal (e.g. failure to make expected gains in weight and height, thoughts, suicidal or self-harming behaviour, agitation, increased blood pressure, agitation, anxiety, and severe irritability, anxiety or insomnia). insomnia). Advise the adolescent to continue the medication even if After one year of treatment: Consult specialist regarding they feel better. The medication should be continued for the continuation of methylphenidate. 9-12 months after the symptoms have resolved to reduce the risk of relapse. Advise against suddenly stopping the medication. If symptoms have been resolved for 9-12 months: Discuss with adolescent and carer risks and benefits to taper off medication. Reduce treatment gradually over minimum 4 weeks, monitor closely for symptom recurrence.",
  "gloss_vi": "Thoughts. » review management plan and monitor adherence to go back to đánh giá step 4 for worsening mood.",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "screening_cues",
      "referral"
    ],
    "life_topics": [
      "sleep",
      "stress",
      "work"
    ],
    "advice_section": [],
    "audience": [],
    "risk_band": "high"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn thoughts. » Review management plan and monitor adherence to Go back to Assessment Step 4 for worsening mood. Go to » SUI psychosocial interventions. for suicidal thoughts. » If on medication, review adherence, side-effects, and dosing. » Explore and address psychosocial stressors in the home, school or work environment, including exposure to violence or other forms of maltreatment. CHILD & ADOLESCENT MENTAL & BEHAVIOURAL DISORDERS 91 92 CMH 3 CHILD & ADOLESCENT MENTAL & BEHAVIOURAL DISORDERS Follow-up 3 MONITOR PHARMACOLOGICAL TREATMENT AS APPLICABLE Additional monitoring if the adolescent Additional monitoring if the child has has been prescribed fluoxetine been prescribed methylphenidate Record prescription and administration details. Record prescription and administration details. Weekly for the first month, then every month: Monitor potential for misuse and diversion. monitor for reported side-effects and changes in mood and Every three months: monitor/record height, weight, blood other symptoms. pressure, reported side-effects, and changes in behaviour. Consult specialist if you identify severe medication side- Consult specialist if you observe medication side-effects effects or adverse events (e.g. new or worsening suicidal (e.g. failure to make expected gains in weight and height, thoughts, suicidal or self-harming behaviour, agitation, increased blood pressure, agitation, anxiety, and severe irritability, anxiety or insomnia). insomnia). Advise the adolescent to continue the medication even if After one year of treatment: Consult specialist regarding they feel better. The medication should be continued for the continuation of methylphenidate. 9-12 months after the symptoms have resolved to reduce the risk of relapse. Advise against suddenly stopping the medication. If symptoms have been resolved for 9-12 months: Discuss with adolescent and carer risks and benefits to taper off medication. Reduce treatment gradually over minimum 4 weeks, monitor closely for symptom recurrence. Thoughts. » review management plan and monitor adherence to go back to đánh giá step 4 for worsening mood."
}